MGX DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action - MGX

Stock Information for Metagenomi Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Metagenomi Inc.

Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
Metagenomi to Present at Jefferies Global Healthcare Conference in London
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
Metagenomi to Present at Upcoming Scientific Meetings

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.